On October 30, 2025, Reinsurance Group of America reported record third-quarter operating earnings, with revenue reaching US$6.20 billion and net income rising to US$253 million, aided by the ...
Alnylam Pharmaceuticals reported third-quarter 2025 earnings, achieving US$1.25 billion in revenue and a net income of US$251.08 million, while also raising full-year revenue guidance to between US$2.